Skip to content

PEANUTS Study

Peanut protein detection in serum and exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21995
Enrollment
10
Registered
2016-05-17
Start date
2016-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers, Food allergy, exercise, intestinal permeability, gezonde vrijwilligers, voedselallergie, inspanning, darmdoorlaatbaarheid

Interventions

Intake of 100grams of roasted peanuts during 2 test days Intake of 5g Lactulose and 1gr L-rhamnose during two test days Blood sampling via venflon cannula at baseline and 30, 60, 90, 120, and 240 min

Sponsors

Wageningen University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - 20-35 year old males and females - Body mass index (BMI) 23-27.5 kg/m2 - Suitable veins for blood sampling - No inhibitory matrix effect in Ara h6 ELISA method - Able to cycle 1h on ergometer

Exclusion criteria

Exclusion criteria: - History of peanut allergy - Known symptoms of immune disease, such as diabetes, gastritis, and coeliac disease. - Pregnant or lactating - Known symptoms of intestinal disease, such as Crohn’s Disease, ulcerative colitis, and irritable bowel syndrome. - Smoking - Use of hard drugs - Use of specific medicines: o Chronic use of NSAIDs: aspirins, ibuprofen, etc. o Drugs having an effect on gastric and/or intestinal function and motility, including antidepressants. - Participation in other scientific studies - Blood donation during the last six weeks before the start and during the study

Design outcomes

Primary

MeasureTime frame
The main study parameter is the difference in serum Ara h6 levels over time between a resting and an exercise condition

Secondary

MeasureTime frame
The secondary endpoint is the level of exercise-induced permeability Other outcomes: Body weight, height, intestinal integrity-related markers, such as I-FABP

Contacts

Public ContactLonneke Janssen Duijghuijsen

Wageningen UR Food and Biobased Research

lonneke.janssen@wur.nl0317-482643

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)